Quoin Pharmaceuticals Ltd DRC (QNRX) Stock Analysis

Quoin Pharmaceuticals Ltd DRC (QNRX) is a publicly traded company in the HEALTHCARE sector. It trades at $4.56, carries a market capitalization of $9.92M. This page summarizes the public market data, fundamentals, and frequently asked questions for QNRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.56
• Market Cap: $9.92M
• EPS: $-10.07
• 52-Week High: $23.50
• 52-Week Low: $4.55

Market Sentiment

Quoin Pharmaceuticals Ltd DRC currently has a Bullish sentiment score of 0.39.

About Quoin Pharmaceuticals Ltd DRC

None

GNG Research Analysis

GNG Research scores Quoin Pharmaceuticals Ltd DRC (QNRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for QNRX.

Frequently Asked Questions

Does QNRX pay dividends?

Quoin Pharmaceuticals Ltd DRC (QNRX) does not currently pay a regular dividend.

What is QNRX's market cap?

Quoin Pharmaceuticals Ltd DRC (QNRX) has a market capitalization of $9.92M with a current stock price of $4.56.